NCT02422602View on ClinicalTrials.gov

Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program

NACompletedINTERVENTIONAL

Enrollment

196

Participants

Timeline

Start Date

November 26, 2013

Primary Completion Date

May 6, 2015

Study Completion Date

May 6, 2016

Conditions

Non-valvular Atrial Fibrillation

Interventions

DRUG

Xarelto

Taking conventional charge

OTHER

Experimental: Personalized information intervention

Trial Locations (1)

34295

Heart and vascular diseases service, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER

NCT02422602 - Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program | Biotech Hunter | Biotech Hunter